NO160824C - Enteralt kontrastmiddel for kjernespinntomografi. - Google Patents

Enteralt kontrastmiddel for kjernespinntomografi.

Info

Publication number
NO160824C
NO160824C NO841773A NO841773A NO160824C NO 160824 C NO160824 C NO 160824C NO 841773 A NO841773 A NO 841773A NO 841773 A NO841773 A NO 841773A NO 160824 C NO160824 C NO 160824C
Authority
NO
Norway
Prior art keywords
enteral
physiologically compatible
spinomography
contractor
nuclear
Prior art date
Application number
NO841773A
Other languages
English (en)
Norwegian (no)
Other versions
NO160824B (no
NO841773L (no
Inventor
Hanns-Joachim Weinmann
Heinz Gries
Heinrich Michel
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO841773L publication Critical patent/NO841773L/no
Publication of NO160824B publication Critical patent/NO160824B/no
Publication of NO160824C publication Critical patent/NO160824C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/806—Electrical property or magnetic property
NO841773A 1983-05-04 1984-05-03 Enteralt kontrastmiddel for kjernespinntomografi. NO160824C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833316703 DE3316703A1 (de) 1983-05-04 1983-05-04 Orales kontrastmittel fuer die kernspintomographie und dessen herstellung

Publications (3)

Publication Number Publication Date
NO841773L NO841773L (no) 1984-11-05
NO160824B NO160824B (no) 1989-02-27
NO160824C true NO160824C (no) 1989-06-07

Family

ID=6198394

Family Applications (1)

Application Number Title Priority Date Filing Date
NO841773A NO160824C (no) 1983-05-04 1984-05-03 Enteralt kontrastmiddel for kjernespinntomografi.

Country Status (9)

Country Link
US (1) US4719098A (fr)
EP (1) EP0124766B1 (fr)
JP (1) JPS6016936A (fr)
AT (1) ATE45287T1 (fr)
CA (1) CA1244346A (fr)
DE (2) DE3316703A1 (fr)
DK (1) DK166528B1 (fr)
FI (1) FI80831C (fr)
NO (1) NO160824C (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735796A (en) * 1983-12-08 1988-04-05 Gordon Robert T Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
EP0330801A1 (fr) * 1983-02-08 1989-09-06 Schering Aktiengesellschaft Particules ferromagnétiques, diamagnétiques ou paramagnétiques avantageuses dans le diagnostic et le traitement des maladies
US5401491A (en) * 1984-05-31 1995-03-28 Guerbet S.A. NMR contrast agents
US5746999A (en) * 1984-11-23 1998-05-05 Schering Aktiengesellschaft Magnetic particles for diagnostic purposes
PT81498B (pt) * 1984-11-23 1987-12-30 Schering Ag Processo para a preparacao de composicoes para diagnostico contendo particulas magneticas
DE3614142C2 (de) * 1985-04-26 1996-03-28 Toshiba Kawasaki Kk Verwendung eines Materials für die Diagnose durch Kernresonanz-Spektroskopie
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
WO1987002893A1 (fr) * 1985-11-18 1987-05-21 Board Of Regents, The University Of Texas System Agents polychelateurs pour l'amelioration de l'image et du spectre (et pour derive spectrale)
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
EP0232751B1 (fr) * 1986-01-23 1991-09-11 E.R. Squibb & Sons, Inc. 4,7,10-Triscarboxyméthyl-1,4,7,10-tétraazacyclododécane substitué en position 1 et analogues
MX174467B (es) * 1986-01-23 1994-05-17 Squibb & Sons Inc 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
IT1213029B (it) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
US5102652A (en) * 1986-07-03 1992-04-07 Advanced Magnetics Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US5248492A (en) * 1986-07-03 1993-09-28 Advanced Magnetics, Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
DE3625417C2 (de) * 1986-07-28 1998-10-08 Schering Ag Tetraazacyclododecan-Derivate
US5252317A (en) * 1986-11-10 1993-10-12 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Amplifier molecules for diagnosis and therapy derived from 3,5-bis[1-(3-amino-2,2-bis (aminomethyl)-propyl) oxymethyl] benzoic acid
US5567411A (en) * 1986-11-10 1996-10-22 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
IT1224416B (it) * 1987-12-24 1990-10-04 Bracco Ind Chimica Spa Chelanti macrociclici e loro chelati
DE3709851A1 (de) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
DE3710730A1 (de) * 1987-03-31 1988-10-20 Schering Ag Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
FR2614020B1 (fr) * 1987-04-14 1989-07-28 Guerbet Sa Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands.
US5154179A (en) * 1987-07-02 1992-10-13 Medical Magnetics, Inc. Device construction and method facilitating magnetic resonance imaging of foreign objects in a body
US4927624A (en) * 1987-11-19 1990-05-22 The University Of Rochester Clay magnetic resonance contrast agents for gastrointestinal comsumption or introduction
GB8813144D0 (en) * 1988-06-03 1988-07-06 Nycomed As Compositions
JPH0678247B2 (ja) * 1988-10-04 1994-10-05 大塚製薬株式会社 Ｎｍｒ造影用鉄含有製剤
US5702683A (en) * 1989-01-24 1997-12-30 The United States Of America As Represented By The United States Department Of Energy Nuclear magnetic resonance contrast agents
JPH0810375B2 (ja) * 1989-04-12 1996-01-31 キヤノン株式会社 定着装置
US5393525A (en) * 1989-07-21 1995-02-28 Nycomed Imaging As Contrast medium comprising superparamagnetic or ferromagnetic particles capable of increasing viscosity after administration
GB8916781D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
GB8916782D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
GB8916780D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
KR0149014B1 (ko) * 1989-09-27 1998-10-15 오쓰카세이야쿠가부시키가이샤 Nmr 조영용 철 함유 제제
US5064636A (en) * 1989-10-19 1991-11-12 Li King C P Paramagnetic oil emulsions as enteric MRI contrast agents
US5120527A (en) * 1989-10-19 1992-06-09 King Chuen Peter Li Paramagnetic oil emulsions as mri contrast agents
EP0693288B1 (fr) * 1990-04-10 1999-10-13 Imarx Pharmaceutical Corp. Polymères commes substances de contraste pour résonance magnétique
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
US5268165A (en) * 1990-10-16 1993-12-07 Biomedical Frontiers, Inc. Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
US5885549A (en) * 1991-02-01 1999-03-23 Imarx Pharmaceutical Corp. Phosphorylated materials as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
US5143716A (en) * 1991-02-01 1992-09-01 Unger Evan C Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
US5240693A (en) * 1991-05-01 1993-08-31 University Of New Mexico Image enhancement by coadministration of biomodulators and structurally modified imaging agents
WO1993018795A1 (fr) * 1992-03-19 1993-09-30 Daikin Industries, Ltd. Milieu de contraste destine a l'imagerie par resonance magnetique et procede de diagnostic
JPH06157355A (ja) * 1992-11-13 1994-06-03 Dai Ichi Seiyaku Co Ltd Ｍｒｉ用粒状製剤
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
US5861138A (en) * 1996-11-20 1999-01-19 Hoechst Celanese Corp. Ligands for MRI contrast agent
US5861140A (en) * 1996-11-20 1999-01-19 Hoechst Celanese Corp. Tripodal paramagnetic contrast agents for MR imaging
US5858329A (en) * 1997-08-21 1999-01-12 Hoechst Celanese Corporation MRI diagnostic procedures using tripodal pyridinyl metal complexes
US5869025A (en) * 1997-08-21 1999-02-09 Hoechst Celanese Corporation Tripodal aromatic heterocycle carboxamide MRI contrast agents
US5820851A (en) * 1997-08-21 1998-10-13 Hoechst Celanese Corporation Tripodal pyridine ligands as MRI contrast agents
US5869026A (en) * 1997-08-21 1999-02-09 Hoechst Celanese Corp. Tripodal carboxamide ligands for MRI contrast agents
US5824288A (en) * 1997-08-21 1998-10-20 Hoechst Celanese Corporation Thio-substituted pyridines as MRI ligand precursors
US5980863A (en) * 1998-11-02 1999-11-09 Eagle Vision Pharmaceutical Corporation Manganese compositions and methods for MRI
AR036354A1 (es) * 2001-08-31 2004-09-01 Takeda Chemical Industries Ltd Preparacion solida
CA2466808C (fr) * 2001-11-21 2009-01-27 E-Z-Em, Inc. Formulations a utiliser dans les procedures medicales et diagnostiques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832457A (en) * 1969-06-20 1974-08-27 Rikagaku Kenkyusho Ferrite contrast media with metallic oxides
FR2210391B1 (fr) * 1972-12-19 1976-07-02 Heitz Fernand
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US4615879A (en) * 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application

Also Published As

Publication number Publication date
JPS6016936A (ja) 1985-01-28
FI80831C (fi) 1990-08-10
DK166528B1 (da) 1993-06-07
US4719098A (en) 1988-01-12
ATE45287T1 (de) 1989-08-15
DE3316703A1 (de) 1984-11-08
EP0124766A2 (fr) 1984-11-14
FI80831B (fi) 1990-04-30
FI841788A (fi) 1984-11-05
NO160824B (no) 1989-02-27
EP0124766A3 (en) 1986-12-30
EP0124766B1 (fr) 1989-08-09
DK220484A (da) 1984-11-05
CA1244346A (fr) 1988-11-08
FI841788A0 (fi) 1984-05-04
NO841773L (no) 1984-11-05
DE3479291D1 (en) 1989-09-14
DK220484D0 (da) 1984-05-03
JPH0477734B2 (fr) 1992-12-09

Similar Documents

Publication Publication Date Title
NO160824C (no) Enteralt kontrastmiddel for kjernespinntomografi.
ES2052766T3 (es) Composiciones magneticas en estado liquido.
DK625987A (da) Lysinsalt af gadolinium-dota kompleks og dets diagnostiske anvendelser
MX9101999A (es) Agentes complejantes e inmunoreactivos radioactivos de objetivo, utiles en composiciones y metodos de formacion de imagen terapeuticos y de diagnostico.
ATE45084T1 (de) Dentales restorationsmaterial.
ATE99544T1 (de) Liposomale radiologische kontrastmittel.
EP0264751A3 (fr) Dérivés d'acides hydroxycarboxyliques et leur utilisation en matériaux d'enregistration
DK0531421T3 (da) Kontrastmedier til ultralydsimagografi
ATE54568T1 (de) Kontrastmittel und deren verwendung.
ES526673A0 (es) Procedimiento para la obtencion de 1,2,3,4-tetrahidropiridinas
ES2024601B3 (es) Proceso para marcar sustancias con tecnicio o renio.
ATE133339T1 (de) Mittel zur magnetischen resonanzabbildung
NO855342L (no) Pyridoyrimidiner og fremgangsmaater for fremstilling derav.
GB1482177A (en) Radioactive selenium and tellurium compounds and their use in diagnostic preparations
IT7921820A0 (it) Procedimento e corredo per il saggio di batteri gram-negativi nei fluidi biologici.
DK8781A (da) Ioniske 5-substituerede 2,4,6-trijodisophthalsyrederivater
White Tuberculosis, Leprosy and Other Diseases Caused by Acid-Fast Bacteria
IT1054620B (it) Poli(idrossimetilene)idroinsolubile biologicamente attivo procedimento per la sua preparazione e suo impiego nella cromatografia per affinita
SU1698676A1 (ru) Способ определени активности щитовидной железы
ATE70440T1 (de) Verwendung von anipamil als artereosklerosemittel.
JPS5251031A (en) Diagostic reagents containing 3'-deoxy-3-iodoglucoe
George The effect of bilirubin on the assay of gentamicin.
Armson The permeability of the sheath and the selective uptake of nicotinic acid in crab axons
GB1391843A (en) X-ray contrast agents
Morris Biliary mercurials in rats exposed to methylmercury chloride

Legal Events

Date Code Title Description
MK1K Patent expired